This course focuses on the critical factors and approaches that managers and sophisticated investors use to identify and value attractive business opportunities and investments in the medical technologies sector. It will provide students with an understanding of the current economic and competitive environment for the development and commercialization of new medical devices, including regulatory, pricing, and reimbursement factors. It will highlight new emerging technologies in the field, and explore how to assess such novel technologies and build commercial models for valuation purposes.
Guest speakers from the medical device industry (company executives, physicians/ surgeons, investors, investment bankers) and investment case studies will be used to provide students with practical insight into this complex sector. Critical issues to be examined include:
- Strategies and risks associated with discovering, developing, and approving new medical technologies, including impact of government oversight and regulation;
- Pricing/reimbursement and health policy/ legislative matters impacting the medical technology sector; - Keys to evaluating novel medical technologies and analyzing business drivers and future performance of medical device & diagnostic companies (public and private);
- How to build commercial models, including valuation methodologies that successful investors use to value/price companies in this sector;
- Conducting due diligence and market analysis on medical technologies from which to formulate investment ideas;
- Considerations in taking long and short investment positions in this sector.
The course is cross-functional in its approach and focuses on real-world" problems currently facing senior managers and investors in this sector. This course will be useful for students interested in careers in the life science and healthcare services sectors, as well as healthcare consulting, investment banking, equity research, venture capital, private equity, and investment management given the large and growing healthcare practices of such firms. Some understanding of, or experience in, the healthcare/medical technologies sector will be highly valuable."
Division: Finance
Center/Program: Healthcare & Pharmaceutical Management Program
Curriculum Pathway: Healthcare, Venture Capital
Corequisite
Complete ANY of the following Courses
Fall 2024
B8746 - 001
Part of Term
MBA - B-Term
Section Syllabus
Download Syllabus
Section Notes
Attendance at the first class is mandatory for all enrolled students and those on a waitlist or who hope to add the class during Add/Drop.
Day(s)
Date(s)
Start/End Time
Room
-
Monday 10/21/2024 - 12/06/2024 6:00PM - 9:15PM Kravis 670
Fall 2023
B8746 - 001
Day(s)
Date(s)
Start/End Time
Room
-
Monday 10/23/2023 - 12/08/2023 6:00PM - 9:15PM Kravis 820